组蛋白在Ph染色体阴性的慢性骨髓增生性肿瘤患者的间充质干细胞中表达并作为潜在的药物靶点

Tolerability of Asciminib vs Investigator-Selected (IS) Tyrosine Kinase Inhibitors (TKIs) in the Phase 3 ASC4FIRST Study in Newly Diagnosed Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

回输采集物成分对恶性血液病异基因造血干细胞移植预后的影响

重型/极重型再生障碍性贫血(V/SAA)和输血依赖性非重度再生障碍性贫血(TD-NSAA)患者体细胞基因突变及其对免疫抑制治疗(IST)疗效的影响

Double-hit and triple-hit multiple myeloma: the clinical manifestation, response and outcome of patients with ultra high-risk cytogenetic abnormalities

FLT3抑制剂在复发难治 AML中诊疗进展

Prime CAR-T细胞治疗R/R B细胞肿瘤单中心数据分享

Zanubrutinib combined with R-CHOP Regimen in the treatment of untreated Non-Germinal Center B-Cell subtype Diffuse large B-cell lymphoma with multiple extranodal involvement.

造血干细胞移植后CMV特异性T细胞在来特莫韦预防中的重建特征

Deciphering the Structural Variants in B Cell Acute Lymphoblastic Leukemia by Optical Genome Mapping

高原红细胞增多症大鼠中红细胞数量、形态、功能及代谢改变

嵌合抗原受体T细胞治疗B淋巴细胞血液肿瘤后巨细胞病毒再激活的观察性研究

费城阳性和费城样ALL免疫靶向ABC方案

WT1 Gene Mutations Impact Post-Transplant Relapse in Myelodysplastic Syndrome with Excess Blasts 2 Patients